QQ客服 官方微博 反馈留言

浏览/检索结果: 共14条，第1-10条 帮助 限定条件 发表日期：2021     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Super-enhancer-associated TMEM44-AS1 aggravated glioma progression by forming a positive feedback loop with Myc 期刊论文 Journal of Experimental & Clinical Cancer Research, 2021, 卷号: 40 作者:  Bian,Erbao;  Chen,Xueran;  Cheng,Li;  Cheng,Meng;  Chen,Zhigang 收藏  |  浏览/下载：299/0  |  提交时间：2021/11/15 Glioma  lncRNA  TMEM44-AS1  Super-enhancer  Myc   Recent Progress and Clinical Development of Inhibitors that Block MDM4/p53 Protein-Protein Interactions 期刊论文 JOURNAL OF MEDICINAL CHEMISTRY, 2021, 卷号: 64, 期号: 15, 页码: 10621-10640 作者:  Zhang, Shiyan;  Lou, Jianfeng;  Li, Yafang;  Zhou, Feilong;  Yan, Ziqin 收藏  |  浏览/下载：64/0  |  提交时间：2021/11/04 Discovery of pyrrolo[2,3-d]pyrimidine derivatives as potent Axl inhibitors: Design, synthesis and biological evaluation 期刊论文 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 卷号: 220, 页码: 18 作者:  Xu, Dandan;  Sun, Deqiao;  Wang, Wei;  Peng, Xia;  Zhan, Zhengsheng 收藏  |  浏览/下载：46/0  |  提交时间：2021/08/17 Axl  Cancer  Inhibitor  Pyrrolo[2,3-d]pyrimidine   Recent Update on Development of Small-Molecule STAT3 Inhibitors for Cancer Therapy: From Phosphorylation Inhibition to Protein Degradation 期刊论文 JOURNAL OF MEDICINAL CHEMISTRY, 2021, 卷号: 64 作者:  Dong, Jinyun;  Cheng, Xiang-Dong;  Zhang, Wei-Dong;  Qin, Jiang-Jiang 收藏  |  浏览/下载：14/0  |  提交时间：2021/08/31 Targeting sorting nexin 10 improves mouse colitis via inhibiting PIKfyve-mediated TBK1/c-Rel signaling activation 期刊论文 PHARMACOLOGICAL RESEARCH, 2021, 卷号: 169, 页码: 11 作者:  Bao, Weilian;  Liu, Xiaohong;  You, Yan;  Hou, Hui;  Wang, Xu 收藏  |  浏览/下载：58/0  |  提交时间：2021/11/16 SNX10  IBD  Macrophage  PIKfyve  TBK1  PPI inhibitor   Structure-Guided Development of Small-Molecule PRC2 Inhibitors Targeting EZH2-EED Interaction 期刊论文 JOURNAL OF MEDICINAL CHEMISTRY, 2021, 卷号: 64, 期号: 12, 页码: 8194-8207 作者:  Du, Daohai;  Xu, Dandan;  Zhu, Licheng;  Stazi, Giulia;  Zwergel, Clemens 收藏  |  浏览/下载：74/0  |  提交时间：2021/08/17 Discovery of a novel, potent and selective small-molecule inhibitor of PD-1/PD-L1 interaction with robust in vivo anti-tumour efficacy 期刊论文 BRITISH JOURNAL OF PHARMACOLOGY, 2021, 页码: 20 作者:  Liu, Chenglong;  Zhou, Feilong;  Yan, Ziqin;  Shen, Lian;  Zhang, Xichen 收藏  |  浏览/下载：26/0  |  提交时间：2021/06/11 immunotherapy  PD-1/PD-L1  TGF-beta  tumour immune microenvironment   KRAS-Mutant Non-Small Cell Lung Cancer: An Emerging Promisingly Treatable Subgroup 期刊论文 FRONTIERS IN ONCOLOGY, 2021, 卷号: 11 作者:  Xie, Mingying;  Xu, Xiaoling;  Fan, Yun 收藏  |  浏览/下载：45/0  |  提交时间：2021/06/15 KRAS-mutant  NSCLC  targeted therapy  immunotherapy  AMG510  MRTX849   The ups, downs and new trends of IDO1 inhibitors 期刊论文 BIOORGANIC CHEMISTRY, 2021, 卷号: 110, 页码: 12 作者:  Chen, Shulun;  Tan, Jing;  Zhang, Ao 收藏  |  浏览/下载：14/0  |  提交时间：2021/08/17 Immunotherapy  Cancer  Indoleamine 2,3-dioxygenase  Tryptophan 2,3-dioxygenase  Inhibitors  Checkpoint Inhibitor   P300/CBP inhibition sensitizes mantle cell lymphoma to PI3K delta inhibitor idelalisib 期刊论文 ACTA PHARMACOLOGICA SINICA, 2021, 页码: 13 作者:  Zhou, Xiao-ru;  Li, Xiao;  Liao, Li-ping;  Han, Jie;  Huang, Jing 收藏  |  浏览/下载：30/0  |  提交时间：2021/06/11 mantle cell lymphoma  idelalisib  drug resistance  P300  CBP  synergistic drug action  PI3Kδ  epigenetics